{
    "paper_id": "PMC7198426",
    "metadata": {
        "title": "Genetic Susceptibility for COVID-19-Associated Sudden Cardiac Death in African Americans",
        "authors": [
            {
                "first": "John",
                "middle": [
                    "R."
                ],
                "last": "Giudicessi",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Dan",
                "middle": [
                    "M."
                ],
                "last": "Roden",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Arthur",
                "middle": [
                    "A.M."
                ],
                "last": "Wilde",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Michael",
                "middle": [
                    "J."
                ],
                "last": "Ackerman",
                "suffix": "",
                "email": "ackerman.michael@mayo.edu",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Since emerging from Wuhan, China in late 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), has infected over 3.2 million individuals worldwide and nearly 1 million in the United States (as of 04/29/2020).1\n,\n2 Despite the institution of measures designed to \u201cflatten the curve\u201d, COVID-19 has claimed the lives of > 225,000 individuals worldwide and > 60,000 individuals in the United States alone (as of 04/29/2020).2 Of note, mortality estimates in some of the hardest hit regions have already or may need to be revised to account for a spike in sudden deaths occurring at home.3\n,\n4\n",
            "cite_spans": [
                {
                    "start": 285,
                    "end": 286,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 289,
                    "end": 290,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 497,
                    "end": 498,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 660,
                    "end": 661,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 664,
                    "end": 665,
                    "mention": "4",
                    "ref_id": "BIBREF33"
                }
            ],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Although most of these deaths are likely directly attributable to COVID-19 (e.g. pulseless electrical activity/respiratory arrests), many of the same regions within the United States have also seen the outpatient prescription volume of COVID-19-direct, heart-corrected QT interval prolonging drug(s), specifically hydroxychloroquine, rise by as much as 22,700% compared to the same time period (03/15-31) in 2019.5 Importantly, recent studies have shown that between 11% and 25% of hospitalized COVID-19 patients treated with chloroquine or hydroxychloroquine and azithromycin had QTc values rise above the critical 500 ms threshold.6\n,\n7\n",
            "cite_spans": [
                {
                    "start": 413,
                    "end": 414,
                    "mention": "5",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 633,
                    "end": 634,
                    "mention": "6",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 637,
                    "end": 638,
                    "mention": "7",
                    "ref_id": "BIBREF40"
                }
            ],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "As a result, a substantial number of COVID-19 patients, prescribed these so-called \u201ccorona cocktails\u201d, may be at increased risk of developing drug-induced long QT syndrome (DI-LQTS) which could deteriorate into drug-induced torsades de pointes (DI-TdP), or worse, drug-induced sudden cardiac death (DI-SCD).8\n,\n9 Therefore, it stands to reason that the same phenomenon (DI-LQTS/DI-TdP) that has already halted one chloroquine/hydroxychloroquine clinical trial7 and led the Food and Drug Administration to caution against the use of chloroquine/hydroxychloroquine outside of the hospital setting/clinical trial10 could also be contributing, at least in small part, to the increase in sudden deaths observed in some COVID-19 epicenters.",
            "cite_spans": [
                {
                    "start": 307,
                    "end": 308,
                    "mention": "8",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 311,
                    "end": 312,
                    "mention": "9",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 459,
                    "end": 460,
                    "mention": "7",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 609,
                    "end": 611,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "In addition, the COVID-19 pandemic has highlighted already alarming health disparities in the United States. For example, in Illinois where age, gender, and racial demographic data are reported for all COVID-19 cases, African Americans account for 26% of confirmed COVID-19 cases, but 43% of COVID-19 deaths.11 A similar trend has been observed across the United States where COVID-19 mortality rates in predominantly black counties are 6-fold higher than in predominantly white counties.12 Although this phenomenon is likely explained by the convergence of multiple cultural and socioeconomic factors12, an underlying genetic susceptibility to SARS-CoV-2 infection, its sequelae (such as hypoxia and inflammation), or the potentially lethal side effects of COVID-19-directed therapies (i.e. DI-TdP and DI-SCD), assuming equal exposure to these medications, could also contribute.",
            "cite_spans": [
                {
                    "start": 308,
                    "end": 310,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 488,
                    "end": 490,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 601,
                    "end": 603,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Current evidence supports the notion that the common ion channel variants p.Asp85Asn-KCNE1 and p.Ser1103Tyr-SCN5A confer an increased risk for DI-LQTS and DI-SCD (Table 1\n).13 Importantly, p.Ser1103Tyr-SCN5A is seen almost exclusively in individuals of African-descent and its frequency in that population (\u223c8%) is higher than that of p.Asp85Asn-KCNE1 (0.2-2.5% depending on ancestry; 0.2% in individuals of African origin; Table 1).13 Furthermore, unlike p.Asp85Asn-KCNE1 whose pro-arrhythmic potential is largely limited to DI-LQTS risk, the modest increase in late/persistent sodium current generated by p.Ser1103Tyr-SCN5A is accentuated markedly by hypoxia/acidosis and has been linked to an increased risk of ventricular arrhythmia (VA) and SCD in African Americans across the age spectrum.13, 14, 15, 16\n",
            "cite_spans": [
                {
                    "start": 173,
                    "end": 175,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 433,
                    "end": 435,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 795,
                    "end": 797,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 799,
                    "end": 801,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 803,
                    "end": 805,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 807,
                    "end": 809,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                }
            ],
            "section": "INTRODUCTION",
            "ref_spans": [
                {
                    "start": 163,
                    "end": 170,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                },
                {
                    "start": 424,
                    "end": 431,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Given the potential of p.Ser1103Tyr-SCN5A to exacerbate outcome-related health disparities in the COVID-19 pandemic, this review was assembled to raise awareness of the multiple mechanism(s) whereby the pro-arrhythmic p.Ser1103Tyr-SCN5A common variant may increase risk for VA/SCD amongst those of African descent as well as the importance of identifying modifiable risk factors for mortality during the COVID-19 pandemic.",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "In individuals of African descent, the common SCN5A-encoded Nav1.5 sodium channel variant p.Ser1103Tyr-SCN5A has been associated with an increased risk of VA/SCD.14\n,\n15\n,\n17 Of note, this pro-arrhythmic potential has been reported to be enhanced by non-genetic risk factors known to reduce cardiac repolarization reserve [e.g. hypokalemia and QTc-prolonging medication exposure; odds ratio 8.7 (95% confidence interval 3.2 \u2013 23.9, P=0.00003)]17 and/or structural heart disease [relative risk 8.4 (95% confidence interval 2.1 to 28.6, P=0.001)] (Table 1).14\n,\n15 Furthermore, p.Ser1103Tyr-SCN5A was associated with potentiation of the QT-prolonging effect of hypokalemia in the 4,476 participants of the Jackson Heart Study suggesting that p.Ser1103Tyr-SCN5A contributes to decreased cardiac repolarization reserve at a population-specific level.18 In addition, two population-based studies reported that p.Ser1103Tyr-SCN5A is over-represented in African American sudden infant death syndrome (SIDS) victims16\n,\n19 providing additional epidemiologic evidence that p.Ser1103Tyr-SCN5A confers an increased risk of sudden death in African Americans regardless of age.",
            "cite_spans": [
                {
                    "start": 162,
                    "end": 164,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 167,
                    "end": 169,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 172,
                    "end": 174,
                    "mention": "17",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 555,
                    "end": 557,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 560,
                    "end": 562,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 846,
                    "end": 848,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 1007,
                    "end": 1009,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 1012,
                    "end": 1014,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                }
            ],
            "section": "p.Ser1103Tyr-SCN5A and VA/SCD-Susceptibility in Individuals of African Descent",
            "ref_spans": [
                {
                    "start": 546,
                    "end": 553,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Besides this epidemiologic evidence, in vitro functional characterization by two independent groups demonstrated that p.Ser1103Tyr-SCN5A alters the inactivation gating of the Nav1.5 sodium channel [negative shift in the voltage dependence of steady state inactivation (V1/2)] and accentuates the sustained/late sodium current that is also the signature of the electrophysiological phenotype displayed by the type 3 long QT syndrome (LQT3)-pathogenic variants.16\n,\n17\n,\n20 That said, the experimental conditions (physiologic pH vs. low intracellular pH) under which p.Ser1103Tyr-SCN5A increased the late sodium current differed in the studies of Splawski et al17 and Plant et al16, respectively. Furthermore, neither study demonstrated an in vitro or in silico ability of p.Ser1103Tyr-SCN5A to prolong action potential duration in the absence of a \u201csecond hit\u201d such as blockade of the rapid-component of the delayed rectifier potassium current (IKr) or intracellular acidosis. This appears to be consistent with i) the exaggerated QTc response to hypokalemia observed in p.Ser1103Tyr-SCN5A-positive Jackson Heart Study participants18 and ii) a circumstance-dependent pro-arrhythmic state in infants (respiratory acidosis caused by hypoxia/apnea)16\n,\n19 and older (DI-LQTS in the setting of \u2265 1 QTc-prolonging drug and advanced structural heart disease) p.Ser1103Tyr-SCN5A-positive African Americans.14, 15, 16\n",
            "cite_spans": [
                {
                    "start": 459,
                    "end": 461,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 464,
                    "end": 466,
                    "mention": "17",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 469,
                    "end": 471,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 659,
                    "end": 661,
                    "mention": "17",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 677,
                    "end": 679,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 1130,
                    "end": 1132,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 1244,
                    "end": 1246,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 1249,
                    "end": 1251,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 1398,
                    "end": 1400,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 1402,
                    "end": 1404,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 1406,
                    "end": 1408,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                }
            ],
            "section": "p.Ser1103Tyr-SCN5A and VA/SCD-Susceptibility in Individuals of African Descent",
            "ref_spans": []
        },
        {
            "text": "Direct and/or indirect myocardial injury/stress, as assessed by cardiac biomarkers such as troponin I and brain-type natriuretic peptide, has emerged as both a prominent and prognostic feature in COVID-19.21, 22, 23 Of note, in an adjusted Cox regression model, the mortality risk associated with elevated cardiac biomarkers/acute cardiac injury was more significant than age and high-risk co-morbid conditions such as chronic obstructive/fibrotic pulmonary disease, diabetes, and a pre-existing history of cardiovascular disease.23\n,\n24 In addition, life-threatening VAs (e.g. ventricular tachycardia/ventricular fibrillation) have been documented in \u223c6% of hospitalized COVID-19 patients and appear to be driven by underlying myocardial injury.25\n",
            "cite_spans": [
                {
                    "start": 205,
                    "end": 207,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 209,
                    "end": 211,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 213,
                    "end": 215,
                    "mention": "23",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 530,
                    "end": 532,
                    "mention": "23",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 535,
                    "end": 537,
                    "mention": "24",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 746,
                    "end": 748,
                    "mention": "25",
                    "ref_id": "BIBREF17"
                }
            ],
            "section": "Implications of p.Ser1103Tyr-SCN5A during the COVID-19 Pandemic",
            "ref_spans": []
        },
        {
            "text": "Proposed mechanisms of acute myocardial injury and resulting VA risk in patients with COVID-19 include i) direct SARS-CoV-2 myocardial infection (e.g. myocarditis), ii) myocardial stress induced by hypoxemic respiratory failure, and/or iii) an exaggerated immune response that results in high levels of circulating cytokines [i.e. interleukin-6 (IL-6), tumor necrosis factor-\u03b1, etc.] directly injuring cardiomyocytes (Figure 1\n).25, 26, 27 Notably, IL-6 may prolong the ventricular action potential via modulation of cardiac ion channel expression/function.27\n",
            "cite_spans": [
                {
                    "start": 429,
                    "end": 431,
                    "mention": "25",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 433,
                    "end": 435,
                    "mention": "26",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 437,
                    "end": 439,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 557,
                    "end": 559,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "Implications of p.Ser1103Tyr-SCN5A during the COVID-19 Pandemic",
            "ref_spans": [
                {
                    "start": 418,
                    "end": 426,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Under normal physiological circumstances, Nav1.5 cardiac sodium channels conduct tiny amount of persistent/late sodium current that contributes minimally to the maintenance of the action potential plateau (i.e. \u2264 0.5% of peak INa).28 However, in the setting of hypoxia, myocardial ischemia, heart failure, and LQT3-causative SCN5A gain-of-function variants, the relative contribution of late sodium current can increase up to ten-fold to 4%-5% of peak INa.16\n,\n20\n,\n28\n,\n29 In turn, this \u201cpathologic\u201d late sodium current can prolong ventricular action potential duration (APD) and predispose to VA/SCD.",
            "cite_spans": [
                {
                    "start": 231,
                    "end": 233,
                    "mention": "28",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 456,
                    "end": 458,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 461,
                    "end": 463,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 466,
                    "end": 468,
                    "mention": "28",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 471,
                    "end": 473,
                    "mention": "29",
                    "ref_id": "BIBREF21"
                }
            ],
            "section": "Implications of p.Ser1103Tyr-SCN5A during the COVID-19 Pandemic",
            "ref_spans": []
        },
        {
            "text": "As discussed previously, p.Ser1103Tyr-SCN5A Nav1.5 sodium channels function normally under physiologic conditions (e.g. intracellular pH of 6.9 to 7.1).16 However, when intracellular pH is decreased in vitro to levels consistent with the respiratory acidosis that occurs secondary to hypoxia/prolonged apnea (e.g. intracellular pH of 6.6 to 6.8), p.Ser1103Tyr-SCN5A Nav1.5 sodium channels generate a pro-arrhythmic, LQT3-like increase in persistent/late sodium current (\u223c5% of peak INa).16 This mechanism was put forward initially to explain the gene-environment interaction(s) responsible for the association between p.Ser1103Tyr-SCN5A and SIDS16. However, the profound hypoxia observed in many COVID-19 cases raises reasonable concern that p.Ser1103Tyr-SCN5A could produce a similar, African American-specific susceptibility to hypoxia-induced VA/SCD in the setting of SARS-CoV-2 infection/COVID-19 (Figure 1).",
            "cite_spans": [
                {
                    "start": 152,
                    "end": 154,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 487,
                    "end": 489,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 645,
                    "end": 647,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                }
            ],
            "section": "Implications of p.Ser1103Tyr-SCN5A during the COVID-19 Pandemic",
            "ref_spans": [
                {
                    "start": 902,
                    "end": 910,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Unfortunately, the increased risk of VA/SCD linked to the potentially pro-arrhythmic p.Ser1103Tyr-SCN5A common variant is likely not limited to the possibility of hypoxia-induced VA/SCD. As succinctly outlined in recent work by Lazzerini et al27, the exaggerated immune response triggered by SARS-CoV-2 infection, specifically elevation of IL-6, likely increases arrhythmia risk via i) modulation of cardiac ion channel expression/function leading to APD prolongation (e.g. direct IL-6-mediated blockade of hERG/Kv11.1 potassium channels), ii) cardiac sympathetic nervous system hyperactivity, and iii) inhibition of cytochrome P450 enzymes involved in the metabolism of some QTc-prolonging drugs (e.g. IL-6 and CYP3A4; Figure 1). The latter effect of IL-6 is particularly important given that a number of COVID-19 pharmacotherapies (e.g. hydroxychloroquine + azithromycin and lopinavir/ritonavir) under investigation and/or in use clinically are known to prolong the QTc and pre-dispose to DI-TdP/DI-SCD (Table 2\n).8\n,\n30\n",
            "cite_spans": [
                {
                    "start": 243,
                    "end": 245,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 1016,
                    "end": 1017,
                    "mention": "8",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 1020,
                    "end": 1022,
                    "mention": "30",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Implications of p.Ser1103Tyr-SCN5A during the COVID-19 Pandemic",
            "ref_spans": [
                {
                    "start": 720,
                    "end": 728,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 1006,
                    "end": 1013,
                    "mention": "Table 2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "Taken together, these data suggest that 1 in 13 African Americans may be at substantially increased risk for potentially lethal VAs, most notably DI-TdP, during the COVID-19 pandemic due to the perfect storm of i) intrinsic genetic-susceptibility (i.e. p.Ser1103Tyr-SCN5A), ii) modifiable environmental risk factors (e.g. electrolyte abnormalities and concurrent QTc-prolonging drug use), and iii) COVID-19-specific risk factors (e.g. profound hypoxemia and cytokine storm; Figure 1). Whether population-specific genetic risk factors such as p.Ser1103Tyr-SCN5A are contributing to the spike in sudden deaths and racial health disparities observed in COVID-19 epicenters remains to be proven and given the lack of banked DNA in these epicenters, this speculation may not even be testable.",
            "cite_spans": [],
            "section": "Implications of p.Ser1103Tyr-SCN5A during the COVID-19 Pandemic",
            "ref_spans": [
                {
                    "start": 474,
                    "end": 482,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Nevertheless, given the potential for COVID-19 to exacerbate known gene-environment interactions pertaining to the potentially pro-arrhythmic p.Ser1103Tyr-SCN5A common variant, it seems reasonable to i) avoid using COVID-19-directed, QTc prolonging drugs (e.g. hydroxychloroquine + azithromycin and lopinavir/ritonavir) unless careful, and preferably personal protective equipment (PPE)-sparing, cardiac monitoring can be implemented (Figure 2\n)8\n,\n31, ii) explore the association between p.Ser1103Tyr-SCN5A and rates of sudden death and COVID-19-related mortality in areas with medical record-linked DNA biobanks (e.g. United Kingdom Biobank and the Jackson Heart Study), iii) investigate further the feasibility of point-of-care p.Ser1103Tyr-SCN5A genetic testing, and iv) determine the clinical utility of QTc-shortening agents such as late sodium current blockers (e.g. mexiletine and lidocaine) and anti-IL-6 targeted therapies (e.g. tocilizumab and sarilumab)27\n,\n32 to better protect at-risk individuals, especially African Americans in the context of the ongoing COVID-19 pandemic.",
            "cite_spans": [
                {
                    "start": 445,
                    "end": 446,
                    "mention": "8",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 449,
                    "end": 451,
                    "mention": "31",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 965,
                    "end": 967,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 970,
                    "end": 972,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                }
            ],
            "section": "Implications of p.Ser1103Tyr-SCN5A during the COVID-19 Pandemic",
            "ref_spans": [
                {
                    "start": 435,
                    "end": 443,
                    "mention": "Figure 2",
                    "ref_id": "FIGREF1"
                }
            ]
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: | Epidemiologic and Functional Data Supporting a Role for p.Ser1103Tyr-SCN5A and p.Asp85Asn-KCNE1 in Drug-Induced Long QT Syndrome Risk.\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: | COVID-19-Directed Pharmacotherapies with DI-TdP/DI-SCD Risk.\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure 1: | Potential gene-environment interactions leading to an increased the risk of ventricular arrhythmias and sudden cardiac death in p.Ser1103Tyr-SCN5A-positive COVID-19 patients. Abbreviations: APD, action potential duration; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; IL-6, interleukin-6; QTc, heart rate-corrected QT interval; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SSRIs, selective serotonin reuptake inhibitors; SCD, sudden cardiac death; and VA, ventricular arrhythmia",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: | Proposed approach to mitigating the risk of DI-TdP/DI-SCD in COVID-19 patients treated with \u2265 1 QTc prolonging drug(s). The estimated 99th percentile QTc values, derived from otherwise healthy individuals, which places a patient in the \u201cGreen Light\u201d category are < 460 ms before puberty, < 470 ms in men, and < 480 ms in women. We estimate that the baseline QTc assessment will place 90% in \u201cGreen Light\u201d, 9% in \u201cYellow Light\u201d, and 1% in \u201cRed Light\u201d status. \u2217Severe COVID-19 cases defined as a RR \u2265 30 (adults) or 40 (children), oxygen saturation \u2264 93%, PaO2/FiO2 ratio < 300, or lung infiltrates involving >50% of the lung field after 24-48 hours. No randomized control trial data is available to support the clinical efficacy of any of the COVID-19-directed QTc prolonging drugs despite the FDA\u2019s Emergent Use Approval of hydroxychloroquine. Abbreviations: COVID-19, coronavirus disease 19; CV, cardiovascular DI-TdP, drug-induced torsades de pointes; DI-SCD, drug-induced sudden cardiac death; ECG, electrocardiogram; QTc, heart rate-corrected QT interval; and SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. Adapted from Giudicessi et al8 with permission. Copyright \u00a9 Elsevier, 2020.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Classification and reporting of potentially proarrhythmic common genetic variation in long QT syndrome genetic testing",
            "authors": [
                {
                    "first": "J.R.",
                    "middle": [],
                    "last": "Giudicessi",
                    "suffix": ""
                },
                {
                    "first": "D.M.",
                    "middle": [],
                    "last": "Roden",
                    "suffix": ""
                },
                {
                    "first": "A.A.M.",
                    "middle": [],
                    "last": "Wilde",
                    "suffix": ""
                },
                {
                    "first": "M.J.",
                    "middle": [],
                    "last": "Ackerman",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Circulation Feb 6",
            "volume": "137",
            "issn": "",
            "pages": "619-630",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Burke",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Creighton",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Mont",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Hogan",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Kutys",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Fowler",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Virmani",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Circulation",
            "volume": "112",
            "issn": "",
            "pages": "798-802",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fraction",
            "authors": [
                {
                    "first": "A.Y.",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "J.I.",
                    "middle": [],
                    "last": "Koontz",
                    "suffix": ""
                },
                {
                    "first": "S.H.",
                    "middle": [],
                    "last": "Shah",
                    "suffix": ""
                },
                {
                    "first": "J.P.",
                    "middle": [],
                    "last": "Piccini",
                    "suffix": ""
                },
                {
                    "first": "K.R.",
                    "middle": [],
                    "last": "Nilsson",
                    "suffix": "Jr."
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Craig",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Haynes",
                    "suffix": ""
                },
                {
                    "first": "S.G.",
                    "middle": [],
                    "last": "Gregory",
                    "suffix": ""
                },
                {
                    "first": "P.M.",
                    "middle": [],
                    "last": "Hranitzky",
                    "suffix": ""
                },
                {
                    "first": "G.S.",
                    "middle": [],
                    "last": "Pitt",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Circ Cardiovasc Genet Apr",
            "volume": "4",
            "issn": "",
            "pages": "163-168",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y",
            "authors": [
                {
                    "first": "L.D.",
                    "middle": [],
                    "last": "Plant",
                    "suffix": ""
                },
                {
                    "first": "P.N.",
                    "middle": [],
                    "last": "Bowers",
                    "suffix": ""
                },
                {
                    "first": "Q.",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Morgan",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "M.W.",
                    "middle": [],
                    "last": "State",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "Kittles",
                    "suffix": ""
                },
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Goldstein",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Clin Invest Feb",
            "volume": "116",
            "issn": "",
            "pages": "430-435",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia",
            "authors": [
                {
                    "first": "I.",
                    "middle": [],
                    "last": "Splawski",
                    "suffix": ""
                },
                {
                    "first": "K.W.",
                    "middle": [],
                    "last": "Timothy",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Tateyama",
                    "suffix": ""
                },
                {
                    "first": "C.E.",
                    "middle": [],
                    "last": "Clancy",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Malhotra",
                    "suffix": ""
                },
                {
                    "first": "A.H.",
                    "middle": [],
                    "last": "Beggs",
                    "suffix": ""
                },
                {
                    "first": "F.P.",
                    "middle": [],
                    "last": "Cappuccio",
                    "suffix": ""
                },
                {
                    "first": "G.A.",
                    "middle": [],
                    "last": "Sagnella",
                    "suffix": ""
                },
                {
                    "first": "R.S.",
                    "middle": [],
                    "last": "Kass",
                    "suffix": ""
                },
                {
                    "first": "M.T.",
                    "middle": [],
                    "last": "Keating",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Science",
            "volume": "297",
            "issn": "",
            "pages": "1333-1336",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Gene-environment interaction between SCN5A-1103Y and hypokalemia influences QT interval prolongation in African Americans: the Jackson Heart Study",
            "authors": [
                {
                    "first": "E.L.",
                    "middle": [],
                    "last": "Akylbekova",
                    "suffix": ""
                },
                {
                    "first": "J.P.",
                    "middle": [],
                    "last": "Payne",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Newton-Cheh",
                    "suffix": ""
                },
                {
                    "first": "W.L.",
                    "middle": [],
                    "last": "May",
                    "suffix": ""
                },
                {
                    "first": "E.R.",
                    "middle": [],
                    "last": "Fox",
                    "suffix": ""
                },
                {
                    "first": "J.G.",
                    "middle": [],
                    "last": "Wilson",
                    "suffix": ""
                },
                {
                    "first": "D.F.",
                    "middle": [],
                    "last": "Sarpong",
                    "suffix": ""
                },
                {
                    "first": "H.A.",
                    "middle": [],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "J.F.",
                    "middle": [],
                    "last": "Maher",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Am Heart J Jan",
            "volume": "167",
            "issn": "",
            "pages": "116-122 e111",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome",
            "authors": [
                {
                    "first": "D.W.",
                    "middle": [],
                    "last": "Van Norstrand",
                    "suffix": ""
                },
                {
                    "first": "D.J.",
                    "middle": [],
                    "last": "Tester",
                    "suffix": ""
                },
                {
                    "first": "M.J.",
                    "middle": [],
                    "last": "Ackerman",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Heart Rhythm May",
            "volume": "5",
            "issn": "",
            "pages": "712-715",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "An interactive web-based dashboard to track COVID-19 in real time",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Gardner",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Infect Dis Feb",
            "volume": "19",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Molecular mechanism for an inherited cardiac arrhythmia",
            "authors": [
                {
                    "first": "P.B.",
                    "middle": [],
                    "last": "Bennett",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Yazawa",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Makita",
                    "suffix": ""
                },
                {
                    "first": "A.L.",
                    "middle": [],
                    "last": "George",
                    "suffix": "Jr."
                }
            ],
            "year": null,
            "venue": "Nature",
            "volume": "376",
            "issn": "",
            "pages": "683-685",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Clinical Characteristics of 138 Hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "JAMA Feb",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China",
            "authors": [
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Qin",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA Cardiol Mar",
            "volume": "25",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Cardiovascular considerations for patients, health care workers, and health systems during the Coronavirus Disease 2019 (COVID-19) pandemic",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Driggin",
                    "suffix": ""
                },
                {
                    "first": "M.V.",
                    "middle": [],
                    "last": "Madhavan",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Bikdeli",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Am Coll Cardiol Mar",
            "volume": "18",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "COVID-19 and the heart",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Akhmerov",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Marban",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Circulation Research",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Late sodium current: A mechanism for angina, heart failure, and arrhythmia",
            "authors": [
                {
                    "first": "J.C.",
                    "middle": [],
                    "last": "Makielski",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Trends Cardiovasc Med Feb",
            "volume": "26",
            "issn": "",
            "pages": "115-122",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Cardiac late Na(+) current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress",
            "authors": [
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Belardinelli",
                    "suffix": ""
                },
                {
                    "first": "W.R.",
                    "middle": [],
                    "last": "Giles",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Rajamani",
                    "suffix": ""
                },
                {
                    "first": "H.S.",
                    "middle": [],
                    "last": "Karagueuzian",
                    "suffix": ""
                },
                {
                    "first": "J.C.",
                    "middle": [],
                    "last": "Shryock",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Heart Rhythm Feb",
            "volume": "12",
            "issn": "",
            "pages": "440-448",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "Considerations for drug interactions on QTc in exploratory COVID-19 (Coronavirus Disease 2019) treatment",
            "authors": [
                {
                    "first": "D.M.",
                    "middle": [],
                    "last": "Roden",
                    "suffix": ""
                },
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "Harrington",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Poppas",
                    "suffix": ""
                },
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Russo",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Circulation",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "The QT interval: An emerging vital sign for the precision medicine era?",
            "authors": [
                {
                    "first": "J.R.",
                    "middle": [],
                    "last": "Giudicessi",
                    "suffix": ""
                },
                {
                    "first": "P.A.",
                    "middle": [],
                    "last": "Noseworthy",
                    "suffix": ""
                },
                {
                    "first": "M.J.",
                    "middle": [],
                    "last": "Ackerman",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Circulation",
            "volume": "139",
            "issn": "",
            "pages": "2711-2713",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "An algorithm for managing QT prolongation in Coronavirus Disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine",
            "authors": [
                {
                    "first": "R.L.",
                    "middle": [],
                    "last": "Mitra",
                    "suffix": ""
                },
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Greenstein",
                    "suffix": ""
                },
                {
                    "first": "L.M.",
                    "middle": [],
                    "last": "Epstein",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "HeartRhythm Case Reports",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X.",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "Z.",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "Z.",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Xiao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Cell Res Mar",
            "volume": "30",
            "issn": "",
            "pages": "269-271",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)",
            "authors": [
                {
                    "first": "X.",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Infect Dis Mar",
            "volume": "9",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia",
            "authors": [
                {
                    "first": "C.Y.",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "F.L.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C.C.",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Clin Toxicol (Phila)",
            "volume": "44",
            "issn": "",
            "pages": "173-175",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds",
            "authors": [
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "K.H.",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Clin Virol Sep",
            "volume": "31",
            "issn": "",
            "pages": "69-75",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "A trial of lopinavir\u2013ritonavir in adults hospitalized with severe COVID-19",
            "authors": [
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Wen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "New England Journal of Medicine",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations",
            "authors": [
                {
                    "first": "E.Z.",
                    "middle": [],
                    "last": "Soliman",
                    "suffix": ""
                },
                {
                    "first": "J.D.",
                    "middle": [],
                    "last": "Lundgren",
                    "suffix": ""
                },
                {
                    "first": "M.P.",
                    "middle": [],
                    "last": "Roediger",
                    "suffix": ""
                },
                {
                    "first": "D.A.",
                    "middle": [],
                    "last": "Duprez",
                    "suffix": ""
                },
                {
                    "first": "Z.",
                    "middle": [],
                    "last": "Temesgen",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Bickel",
                    "suffix": ""
                },
                {
                    "first": "J.C.",
                    "middle": [],
                    "last": "Shlay",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Somboonwit",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Reiss",
                    "suffix": ""
                },
                {
                    "first": "J.H.",
                    "middle": [],
                    "last": "Stein",
                    "suffix": ""
                },
                {
                    "first": "J.D.",
                    "middle": [],
                    "last": "Neaton",
                    "suffix": ""
                },
                {
                    "first": "I.S.S.",
                    "middle": [],
                    "last": "Group",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "AIDS Jan 28",
            "volume": "25",
            "issn": "",
            "pages": "367-377",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "Azithromycin and risk of sudden cardiac death: guilty as charged or falsely accused?",
            "authors": [
                {
                    "first": "J.R.",
                    "middle": [],
                    "last": "Giudicessi",
                    "suffix": ""
                },
                {
                    "first": "M.J.",
                    "middle": [],
                    "last": "Ackerman",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Cleve Clin J Med Sep",
            "volume": "80",
            "issn": "",
            "pages": "539-544",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Chorin",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Dai",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Shulman",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Wadhwani",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Bar-Cohen",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Barbhayia",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Aizier",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Holmes",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Bernstein",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Spinelli",
                    "suffix": ""
                },
                {
                    "first": "D.S.",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "L.A.",
                    "middle": [],
                    "last": "Chinitz",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Jankelson",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF40": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF41": {
            "title": "Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for Coronavirus Disease 19 (COVID-19)",
            "authors": [
                {
                    "first": "J.R.",
                    "middle": [],
                    "last": "Giudicessi",
                    "suffix": ""
                },
                {
                    "first": "P.A.",
                    "middle": [],
                    "last": "Noseworthy",
                    "suffix": ""
                },
                {
                    "first": "P.A.",
                    "middle": [],
                    "last": "Friedman",
                    "suffix": ""
                },
                {
                    "first": "M.J.",
                    "middle": [],
                    "last": "Ackerman",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Mayo Clinic Proceedings",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF42": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}